rebecca pentecost dvm: plaa 2011 keynote slides
DESCRIPTION
Dr. Rebecca Pentecost addresses Pennsylvania Llama and Alpaca Association\'s Annual Meeting at Toftrees Golf and Convention Center, State College, PA on March 24, 2011.TRANSCRIPT
![Page 1: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/1.jpg)
Updates from Ohio State and Camelid Parasite Diagnosis, Control, and Prevention
Rebecca Pentecost, DVM
Hospital for Farm Animals
Veterinary Clinical Sciences
![Page 2: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/2.jpg)
Objectives of Lecture –
• Updates from Ohio State University College of Veterinary Medicine
• Discuss one of the most important problems facing the Camelid producer
• How to approach problem• The most logical and efficient means of
addressing? • Most economical?
• Questions and answers
![Page 3: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/3.jpg)
Update from Ohio State!
• New Theriogenology section• Dr. Carlos Pinto• Dr. Marco DaSilva
![Page 4: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/4.jpg)
Update from Ohio StateUpdate from Ohio StateAlpaca embryo transfer program
Goals of the Program:
-Advance knowledge of Alpaca reproductive
physiology through basic and applied research
-Promote development of assisted reproductive
techniques for alpacas
-Increase reproductive efficiency and accelerate
genetic gain of the herd
![Page 5: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/5.jpg)
Areas of Potential Research:
-Protocols for Superovulation
-Maternal Recognition of Pregnancy (ET time)
-Embryo Cryopreservation
-Endocrinology of Pregnancy
Update from Ohio StateUpdate from Ohio StateAlpaca embryo transfer program
![Page 6: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/6.jpg)
Alpaca embryo – Inner cell mass
![Page 7: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/7.jpg)
Pharmacokinetics and bioavailability of florfenicol in Alpacas
![Page 8: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/8.jpg)
Introduction• Florfenicol has been studied
extensively in cattle
• Florfenicol commonly used empirically in camelids – pharmacologic data have never been established in this species
• Goal: to determine the disposition and bioavailability of florfenicol after IV, SQ, and IM dosing
![Page 9: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/9.jpg)
Study design
• 3 – way crossover design with a minimum of 2 weeks wash-out in between studies
• IV dose, IM dose, SQ dose
• 20 mg/kg florfenicol based upon current weights of each study subject
• 8 Male alpacas• 1.5 to 7 years of age
![Page 10: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/10.jpg)
Study day preparation - IV• Accurate body weight
• Place jugular catheter into each vein
• Nuflor administered IV based upon weight in one jugular catheter
• Samples drawn from contralateral catheter
• Centrifuge to obtain serum• Stored in cryovials in duplicate
![Page 11: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/11.jpg)
Study day preparation – IM,SQ
• Same as IV except one catheter placed for sampling
![Page 12: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/12.jpg)
Sample Analysis• Samples prepared for analysis using solid phase
extraction (SPE)
• Analyte quantitation by HPLC UV224 nm
• Samples reconstituted in mobile phase in brown glass vials after concentration and drying (50 μL injections)
• Complete standard curves were simultaneously extracted from blank alpaca serum on each day of analysis
• Unknown sample concentrations were determined by linear regression analysis of known standard concentrations
![Page 13: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/13.jpg)
Method characteristics
• Sample recovery >85% over range of concentrations tested
• Between and within day accuracy was <10%
• Between and within day precision was <10%
• Limit of quantitation – 0.05 μg/mL
![Page 14: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/14.jpg)
Pharmacokinetic analysis• Individual (IV) plasma concentration versus
time data were modeled using compartmental analysis (1, 2, 3 compartments; Topfit 2.0).
• Most appropriate model was selected base upon the Akaike Information Criterion (AIC) and correlation coefficient (r2)
• 2 Compartmental model provided best fit to data
• Data was described in tabular form as median and range
![Page 15: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/15.jpg)
Parameter Units Median Range
A1 (A) μg/mL 110 52 – 275
λ1 (α) hr-1 4.48 2.57 – 14.8
A2 (B) μg/mL 7.6 4.7 – 31
λ2 (β) hr-1 0.367 0.099 – 1.04
k31 hr-1 1.44 0.33 – 4.66
k1e hr-1 1.32 0.54 – 2.0
k13 hr-1 2.0 0.89 – 9.77
MRT hr 2.56 0.86 – 7.36
T½ (elim) Hr 3.75 1.97 – 6.95
Vss L/kg 0.525 0.25 – 2.54
CL mL/min/kg 5.6 1.6 – 6.2
AUC μg*hr/mL 59.8 54 – 208
Tmax hr 0.00016 0.00011 – 0.014
Cmax μg/mL 109 52 - 275
![Page 16: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/16.jpg)
Serum concentration-time curve IV – Florfenicol (20 mg/kg)
Time (hr)
0 5 10 15 20 25
Ser
um
flo
rfen
ico
l co
nce
ntr
atio
n(
g/m
L)
0.01
0.1
1
10
100
1000
Florfenicol IV 20 mg/Kg0.5 g/mL
![Page 17: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/17.jpg)
Concentration-time curves IM and SQ – Florfenicol (20 mg/kg)
Time (hr)
0 5 10 15 20 25
Ser
um
flo
rfen
ico
l co
nce
ntr
atio
n(
g/m
L)
0
1
2
3
4
5
6
7
Florfenicol IM 20 mg/KgFlorfenicol SQ 20 mg/Kg0.5 g/mL
![Page 18: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/18.jpg)
Conclusions• There were no adverse reactions to the
administration of florfenicol intravenously
• Bioavailability low (~11-40%)
• Half-life of elimination is approximately 4 hr post dosing
• Serum concentrations of florfenicol remain above 0.5 μg/mL for at least 15 h post dosing for all 3 routes
• Peak concentrations of florfenicol after IM dosing are higher and less variable than after SQ dosing.
• Administration of florfenicol once daily should provide adequate serum concentrations for most susceptible bacteria
![Page 19: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/19.jpg)
Acknowledgements
• Dr. Jeff Lakritz
• Dr. Andy Niehaus
• Dave Frederick
• Columbus State Technical Students
• Students and Technicians of The Ohio State VMC
![Page 20: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/20.jpg)
Mycoplasma haemolamae
Transmission, virulence, and in vitro culture
Morris Animal Foundation grant funded
![Page 21: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/21.jpg)
Introduction• A hemotropic parasite that attaches to the
membrane surface of red blood cells
• Originally described and classified as an Eperythrozoon-like organism
• Reclassified to Mycoplasma along with M. suis and M. wenyonii (swine and cattle)
• Based on similarity of the 16S ribosomal RNA gene• PCR testing is useful for parasite detection and
isolation of DNA for sequencing
• Colostral antibodies provide immunity for many diseases and parasites – also for M. haemolamae?
![Page 22: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/22.jpg)
Acridine orange staining
AO stains nucleic acid. Mycoplasma has nucleic acid and stains bright yellow
![Page 23: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/23.jpg)
Clinical and Subclinical Disease• Majority of infected animals show no
signs of disease
• Signs of disease are often nonspecific• Lethargy• Decreased appetite• Fever
• Variable degrees of anemia
• Life threatening disease• Severe anemia• Marked hypoglycemia
![Page 24: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/24.jpg)
Transmission• Poorly understood
• Suspected transplacental transmission
• Potential transmission of pathogens via colostrum
• Biting insect vectors
![Page 25: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/25.jpg)
Study Goals
1. To determine if in utero or colostral transmission was a significant route of infection by Mycoplasma haemolamae for neonatal crias.
2. To identify the presence of colostral antibodies, determine if they affect immune status, and evaluate the relationship between dam parasitemia and colostral antibody excretion.
3. Develop an in vitro culture for ongoing studies
![Page 26: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/26.jpg)
Study Design• Sample collection
• 56 dam/cria pairs identified from a single alpaca farm
• Samples obtained• Blood from dam at parturition (0 hr)• Blood from cria at parturition (0 hr)• Colostrum from dam at parturition (0 hr)• Blood from cria after colostrum
ingestion (48-72 hr)• IgG levels checked at birth and post
colostrum
![Page 27: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/27.jpg)
Sample Processing• DNA extraction
• PCR amplification
• Gel electrophoresis of PCR products
• Positive and negative controls
![Page 28: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/28.jpg)
Colostral Antibodies• Several IFA slides prepared with
parasitemic blood sample
• Colostral samples were diluted 1:10 and 1:100 and incubated on the slides
• A goat anti-llama antibody for flurochrome label incubated with slides
• Antibodies are present if RBCs have areas of fluorescence under UV light microscopy
![Page 29: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/29.jpg)
Culture
• Parasitemic animals identified and samples taken and cryopreserved for ongoing studies and culture maintenance
![Page 30: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/30.jpg)
Initial Results and Conclusions
• Transplacental transmission is uncommon but does occur
• Colostral transmission has not been demonstrated
• Antibodies to M. haemolamae are present in colostrum and seem to provide immunity to the parasite
• Further data analysis and publication pending
![Page 31: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/31.jpg)
Acknowledgements
• Dr. Antoinette Marsh
• Dr. Jeff Lakritz
• Dr. Paivi Rajala-Schultz
• Dr. Josh Daniels
• Jackie Daleccio
![Page 32: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/32.jpg)
Stifle Arthroscopy in Camelids
![Page 33: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/33.jpg)
Study Goal and Design• Arthroscopy is commonly performed in
human, canine, and equine patients
• Minimally invasive approach• Decreased morbidity• Excellent joint surface visualization
• Improvement in diagnosis and therapeutic intervention for stifle pathology
• No previous reports in SAC
![Page 34: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/34.jpg)
Joint Model• PMMA injected
into stifle joint
• Soft tissues removed using concentrated NaOH and hypochlorite solution
• Joint anatomy better defined
![Page 35: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/35.jpg)
Stife Arthroscopy
![Page 36: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/36.jpg)
Selected Cases• Llama with severe OA
• Multiple osteochondral fragments• Possible cruciate rupture – unsure
based on exam and radiograph findings• Very heavily conditioned
• Alpaca with patellar fracture• Small basilar fragment• Minimal joint disease• Otherwise healthy
![Page 37: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/37.jpg)
Acknowledgements
• Dr. Andy Niehaus
• Dr. Elizabeth Santschi
• Dave Frederick
![Page 38: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/38.jpg)
Pharmacokinetics of Midazolam in South American Camelids
Anesthesia and Farm Animal Sections Collaborative Project
Dr. Pam Fry, Dr. Turi Aarnes,
Dr. John Hubbell, Dr. Jeff Lakritz
![Page 39: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/39.jpg)
Introduction• Midazolam classified as a
benzodiazapene
• Uses• Sedation• Anesthetic induction
• Less cardiovascular and respiratory depression as compared to diazepam
• No pharmacokinetic studies have been performed in camelids
![Page 40: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/40.jpg)
Study Design• 6 alpacas
• 3 intact males and 3 intact females
• Route of administration• IM and IV• Crossover study design
• Drug levels measured using HPLC
![Page 41: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/41.jpg)
Results Pending• IV and IM show effect at the dosage
administered• IV effect faster onset and more
profound• Subjective findings indicate significant
sedation• No major side effects have been noted
• Drug bioavailability curves are pending
![Page 42: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/42.jpg)
Future Camelid Research at Ohio State• Dental disease in llamas and alpacas
• Tooth root abscesses occur commonly in llamas and alpacas
• Other ruminants seem less predisposed
• Identification of feed, forage, or other husbandry practices that may predispose to dental disease
• Current plan includes surveying owners in conjunction with retrospective case analysis from hospitalized patients
![Page 43: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/43.jpg)
Update from Ohio State!
• International Camelid Health Conference for Veterinarians
• March 2012 (2nd or 3rd week)• Camelid owners/breeders conference• Veterinary speakers from across the
USA and world
![Page 44: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/44.jpg)
Buckeye Alpaca Show sponsors ICHC speakers
• ICHC for DVM sponsorship by the Buckeye Alpaca Show and OABA?
• Look to OABA and OSU CE website for more details coming soon
![Page 45: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/45.jpg)
ICHC for DVM meeting – tentative schedule• Modules of expertise in
cohesive blocks • Individual
presentation• Summary statements• Discussion/questions
• Reproduction• Medical Diseases• Surgical Diseases• International presence
![Page 46: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/46.jpg)
ICI update –
• Vets only forum• Duplicated by AOBA, NAAF(?)
• Veterinary videos – Collaboration with ARI
• Reference Library• Updated references
• Endowment• Value ~ 700K
![Page 47: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/47.jpg)
Parasites and Camelids –
Should We Be Worried?Becky Pentecost, DVM
The Ohio State University
Veterinary Medical Center
Hospital for Farm Animals
![Page 48: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/48.jpg)
The top 10 reasons camelids develop GI disorders –
• 1. Parasites
• 2. Parasites
• 3. Parasites
• …………..
![Page 49: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/49.jpg)
Why discuss parasites? • What is your parasite management
program?• How developed?
• What is the goal of your parasite management program?
• What is the cornerstone of your parasite management program?
• What would you do if tomorrow, none of the deworming agents worked on any parasites?
![Page 50: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/50.jpg)
Parasitism in SAC
• Camelids can survive pretty well on low quality feed
• Increased digestion and fermentation of even coarse hay
• Water conservation is impressive• Camelid parasites in North America
• SAC have evolved without some of the parasites commonly encountered in NA
![Page 51: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/51.jpg)
Common Nematode ParasitesGI Tract Location ParasitesC3 Haemonchus contortus,
Trichostrongylus, Ostertagia, Camelostrongylus, Teladorsagia, and Marshallagia
Small Intestines Nematodirus, Cooperia, Trichostrongylus
Large Intestines/Cecum Trichuris, Capillaria, and Oesophagostumum spp
![Page 52: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/52.jpg)
Life Cycle Review for Trichostrongyle-types
Infective larvae are ingested during grazing
Eggs hatch, larvae develop to L3 in soil and manure
Eggs passed onto pasture in manure
Adult nematodes in the digestive tract of camelids lay their eggs.
![Page 53: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/53.jpg)
Cestode Parasites• Moniezia most common cestode
• Generally not a primary pathogen
• Severe infections can cause generalized signs of unthriftiness
• Treatment: Fenbendazole, albendazole, or praziquantel
![Page 54: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/54.jpg)
Protozoal Parasites• Coccidia – Eimeria spp.
• Six species reported – 4 are common• E. punoensis, E. alpacae, E. lamae, E.
macusaniensis
• Direct fecal-oral transmission
• Healthy adults rarely show signs of clinical disease
• Juveniles more susceptible• Immunity develops after exposure
![Page 55: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/55.jpg)
Coccidia• Damage intestinal epithelial mucosal
cells
• Diarrhea may remain after clearing infection
• Coccidiostats during times of high stress may help prevent outbreaks
• Amprolium• Sulfadimethoxine• Ponazuril• Toltrazuril
![Page 56: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/56.jpg)
E. mac – A Big Deal?• First reported in the US in 1988
• Slightly longer prepatent period than other Eimeria spp
• Widespread geographic distribution
• Can be subclinical carriers/shedders
• Can cause serious disease/death
• Evaluate for signs of infection• Protein levels of particular concern• Ponazuril generally accepted treatment• Toltrazuril becoming more popular
![Page 57: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/57.jpg)
Indications of GI Parasitism• Often nonspecific
• Unthrifty appearance• Anorexia• Slow or stunted growth• Weight loss / Lower BCS
• Diarrhea
• Pale mucous membranes
• Edema (submandibular or ventral)
![Page 58: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/58.jpg)
Fecal Exams• Preferred methodology
• Concentrated sugar solution (1.27 SG)• Centrifugation• 30-60 minute flotation time
• Qualitative vs. Quantitative Analysis
• Fecal Egg Count Reduction Test (FECRT)
![Page 59: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/59.jpg)
Other Diagnostics?
• PCV/TP
• CBC
• Blood transfusion may be required in severely anemic animals as a stabilization measure
![Page 60: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/60.jpg)
Anthelmintics• Accurate body weights
• Deworming history• Timing• Fecal counts• Effectiveness of previous dewormers
• Targeted treatment
• Resistant parasites
• Limited dewormers available – no new ones in sight…
![Page 61: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/61.jpg)
Available DewormersClass Drug Dosage Route
Avermectins Ivermectin 1.5 mL/100 lbs SQ
Doramectin 2.0 mL/100 lbs SQ
Cydectin
Benzamidazoles Fenbendazole 9 mg/lb Oral
Albendazole 5.5 mg/lb Oral
Imidazothiazole derivative
Levamisole 4 mg/lb Oral
Depolarizing neuromuscular blocking agent
Pyrantel pamoate 8 mg/lb Oral
Antiprotazoal/Coccidiostats
Ponazuril 9 mg/lb Oral
Toltrazuril
Amprolium
Sulfadimethoxine
![Page 62: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/62.jpg)
Deworming Conundrum• Meningeal worm
• Deworming recommendations to prevent infection• Ivermectin• Doramectin• Treat monthly
• What is the downside to this treatment pattern?
• Resistant GI parasites
![Page 63: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/63.jpg)
Monthly deworming with Ivermectins – How effective against whipworms? • Ivermectins are of highly variable efficacy against
Trichuris spp. in swine. • Riviere J, Papich M, Veterinary Pharmacology and
Therapeutics 9th Ed. 2009. pp. 1131
• Ivermectin at higher doses for dogs and cats• Riviere J, Papich M, Veterinary Pharmacology and
Therapeutics 9th Ed. 2009. pp. 1131
• Parasite fecundity – Low
• Eggs high density; must use appropriate centrifugation techniques
• Camelids highly susceptible to whipworm infestation
![Page 64: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/64.jpg)
Monthly deworming with Ivermectins – How effective against mites?
• Reportedly highly effective against Sarcoptic mange, Psoroptic mange
• Effective against sucking lice• Chorioptic mange?
• Biology of this parasite?• May spend weeks off of host (environment)• Treatment with Doramectin or Ivermectin
• G.L. D’Alterio, Vet. Parasit. 2005; 130 (3-4): 267-275• Fipronil application (topical, spray)
![Page 65: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/65.jpg)
FECR tests – Goats 2001Anthelmintic EPG (2 wk post) FECR % (95% CI)
Control 3827
ABZ 1450 62 (35-78)
Dora 917 76 (39-91)
FBZ 3460 10 (0-42)
IVM 844 78 (5-95)
LEV 335 91 (81-96)
Morantel 1990 48 (11-70)
MOXI 0 100 (100)
ABZ + IVM 445 88 (74-95)
Terrill TH, et al., 2001; Vet. Parasitol. 97:261-268
![Page 66: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/66.jpg)
FECR tests – Goats 2003• ABZ resistance on 14/15 farms• IVM resistance on 17/18 farms• LEV resistance on 6/18 farms• MOXI resistance on 1/18 farms• Resistance to multiple drugs
• 14/15 farms (ABZ, IVM)• 5/15 farms (ABZ, IVM, LEV)
• FEC reduction (%)• ABZ 67, IVM 54, LEV 94, MOXI 97
• H. contortus and Trichostrongylus most common isolated larvae
Mortenson LL, et al., 2003; JAVMA 223:495-500
![Page 67: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/67.jpg)
FECR tests – Sheep and Goats• Haemonchus resistance
• 45/46 farms – BZD• 25/46 farms – LEV• 35/46 farms – IVM • 11/46 farms – MOXI
• Resistance to all 3 classes• 22/46 farms
• Resistance to all 3 classes + MOXI• 8/46 farms
• H. Contortus and Trichostronylus most common identified parasites
Howell SB, et al., 2008; JAVMA 233:1913-1919
![Page 68: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/68.jpg)
Parasite resistance in SAC?
• What is the incidence of resistant nematodes in SAC?
• Gillespie RM et al., 2010; Vet. Parasit. 172:168-171• Resistance to IVM (Llama, Alpaca farms)• Resistance to FBZ (Llama farms)• Resistance to MOX (Llama farm)• No Resistance to LEV on any farm tested
![Page 69: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/69.jpg)
Parasite resistance and anemia
• Seeing increased incidence of parasite problems
• Many of these present with severe anemia
• Haemonchosis?
![Page 70: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/70.jpg)
H. Contortus – C3, alpaca
![Page 71: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/71.jpg)
Blood loss ?
• Blood volume in llamas 63 ± 4 mL/Kg, alpacas 72 ± 5 mL/Kg
• Blood volume 9L (llama), 4.9L (alpaca)
• Anemia hemorrhagic in nature• Adult worms suck blood for 12 min, 7 min
continued bleeding after worm detachment
• Sheep carrying 3-4k female worms lose up to 150-200 mL whole blood/day
Moore DM, Vet. Hematology; 5th Ed. Pp. 1184-90Le Jambre LF, Int. J. Parasitol, 1995; 25:269-73Rowe JB, et al., British J Nutrition 1988; 59:125-39
![Page 72: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/72.jpg)
Fecal ooccult blood –
![Page 73: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/73.jpg)
The Predicament – Death of your animals
• Monthly deworming for meningeal worm
• Selection for resistant nematodes
• Overdosing dewormers
• Anemia and death
![Page 74: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/74.jpg)
Building a parasite program
• What things can you incorporate?• 1. Camelid behavior• 2. Pasture management • 3. Biological controls
![Page 75: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/75.jpg)
Peculiarities of camelids – • Dung piles
• Most important aspect of camelid behavior relative to GI parasitism management
• Overcrowding
![Page 76: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/76.jpg)
Map of property – Why?
![Page 77: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/77.jpg)
Integrated parasite management
• Clean or safe pastures • Pastures not grazed for 6-
12 mos • Pastures grazed by other
species• Pastures where hay is
removed• Pastures rotated with
harvested crops• Tilled land put into pasture• Pastures rested for varying
time period• 60 -120 day between grazing• Improved pasture outweighs
parasite burdens
![Page 78: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/78.jpg)
Grazing strategy• 80% of worm burden in lower 2” of grass
• Grazing taller grass will limit exposure
• Browsing
• Wait until dew or rain dries• Turn out later in day
• Multi-species grazing
• Alternative forages• Chicory• Sericea lespedeza• Birdsfoot trefoil
![Page 79: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/79.jpg)
Other Management Techniques• Feeding off the ground (bunks)
• Eliminating standing water
• Regular removal of dung piles and pen sanitation
• Biosecurity - Quarantine incoming animals
![Page 80: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/80.jpg)
![Page 81: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/81.jpg)
Anemia in South American camelids –
• Gastrointestinal parasitism• Primarily Haemonchus
• Blood borne pathogens• Mycoplasma haemolamae
• Toxic• Red Maple
• Neoplasia• Lymphoma
![Page 82: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/82.jpg)
Review of recent anemia cases from OSU VMC
• 46 Animals (35 Alpaca, 11 Llama)
• 33 female, 13 male; 4.2 ± 3.5 yrs• 41 heavily parasitized, 2 obstetrical complications, 1 peritonitis, 1 tetrology of fallot.
![Page 83: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/83.jpg)
Iron deficiency anemia – • Microcytic, hypochromic, reduced
MCHC, hypoferremia, reduced serum ferritin conc, decreased % transferrin saturation and normal to increased TIBC
• Moderate anemia, PCV 18-22, RBC# normal, hemoglobin ½ normal, microcytic, low MCHC
• Morin DE et al, Vet Pathol. 1992; 400-4
![Page 84: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/84.jpg)
Iron deficiency anemia
• 2/3 of body iron is present in RBC
• Bone marrow, spleen, liver
• Serum iron drops first, followed later by BM decrease and change in RBC morphology (hypochromasia, microcytosis)
• Vitamin B12 deficiency• Macrocytic anemia
From: Smith BP, 2009; 4th Ed., 2009
![Page 85: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/85.jpg)
Total plasma protein and red cell parameters – presentation
Analyte Mean ± sd Range Median Reference
TPP (Gm/dL) 5.2 ± 0.72 3.7 – 6.6 5.3 5.4 – 7.2
HCT (%) 9.9 ± 5.3 4 – 25 8 24 – 35
HgB (Gm/dL) 4.2 ± 2.3 1.6 – 11 3.6 9.1 – 16.2
RBC (x 1012/L) 4.2 ± 2.5 1.4 – 10.5 3 8.8 – 15.4
MCV (fL) 25 ± 6 12.7 - 44 24 21 - 30
MCH (pg) 10 ± 2 6.5 – 16 10 7.7 - 13
MCHC (g/dL) 42 ± 5.7 35.7 - 48 41 39 - 46
NRBC (ABS) 28 ± 47 0 - 257 15 0 – 0
NRBC
(#/100 WBC)4.8 ± 8.2 0 - 42 2 0 – 1
![Page 86: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/86.jpg)
RBC abnormalities - ?
![Page 87: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/87.jpg)
Polychromatic, hypochromatic, dacryocytes
![Page 88: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/88.jpg)
Serum Fe, TIBC, UIBC in anemic Alpacas
Analyte UnitsAnemic
(median)Range
Normal
(median)Range
Serum
Feμg/dL 43 ± 42*
(22)2 – 121
95 ± 35
(96)37 - 168
TIBC μg/dL261 ± 65
(266)172 – 363
248 ± 44
(242)186 – 339
UIBC μg/dL
218 ± 71
*(209)
70 - 309153 ± 51
(164)61 – 230
Data from 13 anemic and 13 normal Alpacas*Indicates significant difference from normal using t-test(P<0.05); power with α = 0.05 are 0.915, 0.67 respectively
![Page 89: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/89.jpg)
“Otis May” – Presentation
• Down, weak, pale
• No milk in udder
• Cria is hungry and trying to nurse
• Ocular membranes
![Page 90: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/90.jpg)
Case Management• White mucous membranes
• PCV – 7%
• TP – 5.0 g/dL
• CBC indicates regenerative response (NRBCs elevated)
• Mild derangements on biochemical profile
• Blood transfusion – 1-2 units whole blood
• Iron and Vitamin B12 supplementation
• Fecal examination, PCR for M. haemolamae, etc.
![Page 91: Rebecca Pentecost DVM: PLAA 2011 Keynote Slides](https://reader037.vdocuments.net/reader037/viewer/2022110306/555086c1b4c9051e5b8b4a53/html5/thumbnails/91.jpg)
Questions?